Mangaluru, May 15: Mohammed Kana, son of late Ismail Kana and grandson of late Dr M S Bapanad Mulki passed away in Riyadh, Saudi Arabia due to heart attack on Thursday. He was 57.
Hailing from Mangaluru, Mohammed Kana was working in Saudi Arabia for past 30 years. He is survived by his wife, son and a daughter.
He was involved in various social and welfare activities in India and Saudi Arabia. His tragic demise has left huge vacuum in his family and community at large.
Mangaluru, Apr 12: Dakshina Kannada district in-charge minister Kota Srinivas Poojary on Saturday, April 11, welcomed the State government’s decision to permit fishing during the lockdown that’s now extended till April 30.
“We welcome the Centre’s decision to permit fishing during the lockdown. This directive comes as a huge relief for the fishing community,” Poojary told newsmen here.
Poojary informed that 14,000 boats will be deployed for fishing. Keeping the need for social distancing in mind only five crew members will be allowed on a boat. The boats can set sail in the morning and should return by evening.
Bengaluru, Feb 3: The Karnataka government on Monday ordered high alert across border districts after neighbouring Kerala reported the second confirmed case of dreaded n-CoV Coronavirus. District administrations in Kodagu, Mangaluru, Chamarajanagar and Mysuru that share boundary with Kerala have been put on high alert over the movement of people with suspected cases.
In a statement released on Monday, the Health and Family welfare department said that these districts have been directed to immediately report to the State Surveillance Unit (SSU) if they come across any suspected cases of people infected with Coronavirus.
Currently, about 51 people who returned from Coronavirus-affected regions have been identified and 46 are under home isolation across Karnataka. So far, 44 samples have been sent to the National Institute of Virology, Pune for analysis and out of which 29 samples have revealed negative results. Yet, the state government has put in all possible measures to check the spread of the virus in any part of the state.
The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19.
“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar.
“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”
The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.
The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.
The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.
“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.
Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease.
The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.
Comments
Inna Lillahi Wa Inna Ilaihi Rajihoon
Add new comment